Which of the following is NOT a narcotic agonist-antagonist?

Prepare for the DAANCE Module 3 Exam with flashcards and multiple-choice questions. Each question comes with hints and explanations. Ensure your success!

Multiple Choice

Which of the following is NOT a narcotic agonist-antagonist?

The classification of narcotic medications includes various types based on their pharmacological effects. Narcotic agonist-antagonists are drugs that partially stimulate opioid receptors while simultaneously blocking other opioid receptors, which can help manage pain with a lower risk of dependence compared to pure agonists. In this context, meperidine is a pure opioid agonist, meaning it fully activates opioid receptors to produce its effects, primarily used for moderate to severe pain relief. Because it does not possess the antagonist properties that would classify it as an agonist-antagonist, it does not fit into that specific category. Pentazocine, nalbuphine, and butorphanol all exhibit agonist-antagonist characteristics. They stimulate some opioid receptors while blocking others, providing analgesic effects while potentially reducing the likelihood of opioid abuse and dependence. Understanding the distinction between pure agonists and agonist-antagonists is important for safe and effective pain management strategies in dentistry and other medical settings.

The classification of narcotic medications includes various types based on their pharmacological effects. Narcotic agonist-antagonists are drugs that partially stimulate opioid receptors while simultaneously blocking other opioid receptors, which can help manage pain with a lower risk of dependence compared to pure agonists.

In this context, meperidine is a pure opioid agonist, meaning it fully activates opioid receptors to produce its effects, primarily used for moderate to severe pain relief. Because it does not possess the antagonist properties that would classify it as an agonist-antagonist, it does not fit into that specific category.

Pentazocine, nalbuphine, and butorphanol all exhibit agonist-antagonist characteristics. They stimulate some opioid receptors while blocking others, providing analgesic effects while potentially reducing the likelihood of opioid abuse and dependence.

Understanding the distinction between pure agonists and agonist-antagonists is important for safe and effective pain management strategies in dentistry and other medical settings.

More practice questions